SCHEMBL9422262

SCHEMBL9422262

[CH2]CC(NC)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Magnesium Chloride Anhydrous SCHEMBL22089878 0.87
SCHEMBL28901822 0.87
SCHEMBL5383115 0.74
SCHEMBL14715941 0.72
SCHEMBL385955 0.67
SCHEMBL11288411 0.67
SCHEMBL28239890 0.65
SCHEMBL1278191 0.65
SCHEMBL381096 0.64
SCHEMBL386419 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9708321-B2 Spiro-quinazolinone derivatives and their use as positive allosteric modulators of mGluR4 MERCK PATENT GMBH (DE) 2017-07-18 US claimed
US-20150361079-A1 Spiro-Quinazolinone Derivatives and their Use as Positive Allosteric Modulators of mGluR4 MERCK PATENT GMBH (DE) 2015-12-17 US claimed
EP-2951179-A1 SPIRO-QUINAZOLINONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS Merck Patent GmbH (DE) 2015-12-09 EP claimed
WO-2014117920-A1 SPIRO-QUINAZOLINONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS MERCK PATENT GMBH (DE) 2014-08-07 WO claimed
WO-1994021274-A1 SYNERGISTIC COMBINATION OF ETHAMBUTOL AND A GLYCOPEPTIDE ANTIBIOTIC GRUPPO LEPETIT S.P.A. (IT) 1994-09-29 WO claimed
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 EP disclosed
US-10626095-B2 Cyanotriazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-04-21 US disclosed
US-9708321-B2 Spiro-quinazolinone derivatives and their use as positive allosteric modulators of mGluR4 MERCK PATENT GMBH (DE) 2017-07-18 US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 US disclosed
EP-3022199-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2016-05-25 EP disclosed
US-20150361079-A1 Spiro-Quinazolinone Derivatives and their Use as Positive Allosteric Modulators of mGluR4 MERCK PATENT GMBH (DE) 2015-12-17 US disclosed
WO-2015008872-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-01-22 WO disclosed
WO-1994021274-A1 SYNERGISTIC COMBINATION OF ETHAMBUTOL AND A GLYCOPEPTIDE ANTIBIOTIC GRUPPO LEPETIT S.P.A. (IT) 1994-09-29 WO disclosed
EP-0344660-B1 THIOPHENE DERIVATIVES BASF Aktiengesellschaft (DE) 1992-07-22 EP disclosed
US-4937256-A Herbicides BASF AKTIENGESELLSCHAFT (DE) 1990-06-26 US disclosed
EP-0344660-A1 Thiophene derivatives BASF Aktiengesellschaft (DE) 1989-12-06 EP disclosed
CN-88101000-A The alkylamide of the replacement of teicoplanin compounds 1988-09-14 CN disclosed
US-4026934-A INSECTICIDES, ACARICIDES, FUNGICIDES BAYER AKTIENGESELLSCHAFT (DT) 1977-05-31 US disclosed